InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: davidal66 post# 653

Sunday, 02/26/2017 11:08:30 PM

Sunday, February 26, 2017 11:08:30 PM

Post# of 2099
That is a nice writeup, davidal66. I agree, especially about the timing of the interim analysis -- about July to Sept would be my guess; hoping the VB-111 arm pushes it out to later.

Regarding the CLDX trial, I think the main takeaway was what CLDX did in phase 2. In phase 2, they selected patients so that their outcomes would prove favorable for CLDX. In phase 3, they couldn't do that and the truth came out.

I don't think VBLT did that for VB-111.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News